| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f4c2477bdea308bc9dec3feded37457 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 |
| filingDate |
2002-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0851457a797ec5a52dc0576f7316e43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41eb04e2bca6a1f77627e45250d34418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0ada0e4dfd3f1358d83bc0b9d19a29e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaec0704061962cd9d7c4f3d3fb29c82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7f9a24b54a02fe830f4b1decffe5d87 |
| publicationDate |
2004-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2004203745-A |
| titleOfInvention |
Hepatoma cell growth inhibitor containing menatetrenone |
| abstract |
[Problem] It is known that high levels of PIVKA-II are closely related to subsequent progression to portal vein invasion in hepatocellular carcinoma. [Solution] Menatetrenone-containing hepatoma cell growth inhibitor, menatetrenone-containing JAK-STAT signaling inhibitor, and menatetrenone-containing JAK-STAT signaling The object is achieved by providing a therapeutic agent for hepatocellular carcinoma and a method for suppressing the proliferation of hepatoma cells by suppressing PIVKA-II production. [Selection diagram] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110010113-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2013038907-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007143450-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013038907-A1 |
| priorityDate |
2002-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |